JDD Special Focus

Acne Case Reports

Stay up-to-date on new clinical findings on Acne. View the latest articles, case reports, editorial features, supplements, Podcast episodes and more!

 

Case Reports

Microneedling for Treatment of Acne Scars: Considerations on the Successful Management of This Aesthetic Procedure

Microneedling is a minimally invasive procedure for treating acne scars which has already been well-established, but it has been reborn in recent years because of innovative findings. It presents many advantages in comparison with other techniques more frequently used such as laser resurfacing and deep chemical peelings; in particular, it consents to achieve good or excellent results with a minimal time (2-3 days) of recovery and rare complications, even in dark phototypes.1,2 

Read Now

Sponsored

Featured Unlocked Article

Integrating Dermocosmetic Therapy for Acne: Addressing Severity Levels in Real-Life Experiences

Treating acne is not just about prescriptions—it is about pairing the right skincare routine with medical therapy. This JDD article highlights how combining pharmacological treatments with a personalized dermocosmetic regimen can improve results and keep patients on track.

Read Now

Derm Atlas

One of the key characteristics of acne is post-inflammatory hyperpigmentation and is most noticeable in darker skin tones. It is also important to point out that keloidal or hypertrophic scarring may result and should be considered when treating patients.

Here we can appreciate the erythema of inflammatory papules in lighter skin tones and the brown coloration of inflammatory papules mimicking post-inflammatory hyperpigmentation in darker skin tones.

Read Now

Podcast Episodes

State of Acne Management: Stud or Dud?

Do not pop, rather pick a therapeutic strategy from the wide array of new….oh wait, nevermind.  The world of acne treatment R&D is unfortunately shrinking as payors pick away at the medical necessity of managing the most common inflammatory skin disease. Like Marty McFly fading in that famous family photo, the spotlight on acne is shifting, enough to make Dr. Pimple Punisher Dr. Hilary Baldwin pick up a bottle of Prozac. But all hope is not lost.

Join JDD Podcast host Dr. Adam Friedman as he and Dr. Baldwin scour the therapeutic landscape and take a sharp left into the over the counter space to review accessible options to manage both the today and tomorrow of Acne Vulgaris, the symbiosis between RX and OTC to address barrier dysfunction, scarring and hyperpigmentation.

Listen Now

Sponsored

Dermatology News

Featured ArticlesLatest NewsRosaceaClascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial
September 4, 2026

Clascoterone Cream 1% is Safe and Effective for Papulopustular Rosacea: A Phase 2 Clinical Trial

Investigating Clascoterone Cream 1% for Papulopustular Rosacea: Key Takeaways  This is a must-read article from JDD for clinicians seeking fresh therapeutic avenues for chronic facial dermatoses. Managing papulopustular rosacea often…
Journal of Drugs in Dermatology JDD featuring Optimizing Melasma Management With Topical Tranexamic Acid: An Expert ConsensusDyspigmentationFeatured ArticlesLatest NewsOptimizing Melasma Management With Topical Tranexamic Acid: An Expert Consensus
September 4, 2026

Optimizing Melasma Management With Topical Tranexamic Acid: An Expert Consensus

From the Vault: Managing Recurrent Hyperpigmentation Beyond Standard Hydroquinone Regimens Given its complex pathogenesis, chronicity, and high rates of recurrence, melasma remains one of the most challenging conditions in aesthetic…
Featured ArticlesFeatured PodcastLatest NewsPodcastPodcast HighlightsShots, Shots, Shots: Is There Such a Thing as One Too Many?
September 4, 2026

Shots, Shots, Shots: Is There Such a Thing as One Too Many?

Guest: Dr. Joseph Bax Corticosteroid injections are everywhere in musculoskeletal medicine. Epidurals, joints, facets, bursae: when inflammation and pain are the targets, steroids have long been one of the sharpest…
Featured ArticlesJDD in the MediaLatest NewsJDD in the News: UV Light as a Workplace Hazard
September 2, 2026

JDD in the News: UV Light as a Workplace Hazard

Healio featured two Journal of Drugs in Dermatology studies in recent articles, including an article on UV light as an underappreciated workplace hazard. The study, "Sun Exposure and Cancer Outcomes…